As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Elliott is a very successful and astute activist investor. The firm's team includes analysts from leading tech private eq ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

Charles River Laboratories, a leading provider of preclinical drug development services, has reported impressive results in ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

The impetus: an announcement from the US Food and Drug Administration in early April indicating that the agency plans to phase out animal tests—a longtime cornerstone of preclinical drug testing ...